FDAnews Announces: Accelerating Post-approval Change Management with ICH Q12 and Mondern Technologies Webinar, Sponsored by Veeva Systems, April 18, 2019

Thursday, April 4, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

Thursday, April 18, 2019: 12:00 p.m. - 1:00 p.m. EDT - Adopting ICH Q12 and modern technologies can reduce the number of changes that require regulatory approval as well as accelerate evaluation, implementation, and global approval of a change.

FALLS CHURCH, Va., April 04, 2019 /PRNewswire-PRWeb/ -- Ever wonder about making the global post-approval change management

(PACM) processes more efficient?

It's a topic we're discussing on Thursday, April 18 at 12:00 pm E.T. during a one-hour webinar.

The goal of our webinar is for attendees to gain a better understanding on ICH Q12. One will also learn how modern technologies are improving change management, including:

  • Key aspects and potential benefits of ICH Q12
  • Best practices and approaches to top PACM challenges
  • Approaches to manage 'established conditions'
  • How technology can support ICH Q12 and simplify change management
  • Innovative ways leading pharma companies are addressing PACM

Register here to be part of the discussion led by experts from Axendia Inc. and Veeva Systems.

We hope you can join us, The Veeva Quality Team

Webinar Details: Accelerating Post-approval Change Management with ICH Q12 and Mondern Technologies Sponsored by Veeva Systems An FDAnews Webinar Thursday, April 18, 2019 ˇ 12:00 a.m. – 1:00 p.m. ET http://info.fdanews.com/accelerating-post-approval-change-management-with-ich-q12-and-modern-technologies?free_webinar_source=HP

Easy Ways to Register: Online: http://info.fdanews.com/accelerating-post-approval-change-management-with-ich-q12-and-modern-technologies?free_webinar_source=HP By phone: 888-838-5578 or 703-538-7600

About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDANEWS



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store